版本:
中国

BRIEF-Ardelyx Qtrly loss per share $0.59

May 5 Ardelyx Inc:

* Ardelyx reports first quarter 2017 operating results and highlights recent progress

* Ardelyx Inc - on track to report data from t3mpo-1 phase 3 trial of tenapanor in ibs-c in q2 2017

* Ardelyx Inc qtrly loss per share $0.59

* Q1 earnings per share view $-0.68 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐